These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Matters of the heart: assessing the cardiovascular safety of new drugs. Konstam MA Am Heart J; 2003 Oct; 146(4):561-2. PubMed ID: 14564304 [No Abstract] [Full Text] [Related]
27. Merck withdraws Vioxx; FDA issues public health advisory. FDA Consum; 2004; 38(6):11. PubMed ID: 15675020 [No Abstract] [Full Text] [Related]
29. [Probable cardiac failure due to rofecoxib]. García Nicolás FJ Aten Primaria; 2005 Apr; 35(6):325-6. PubMed ID: 15826518 [TBL] [Abstract][Full Text] [Related]
30. The Vioxx debacle revisited. Good CB; Kelley CL Am J Med; 2005 Sep; 118(9):1055-6; author reply 1056-7. PubMed ID: 16164902 [No Abstract] [Full Text] [Related]
31. [Extreme sinus bradycardia (30/min) with acute right heart failure under tizanidine (Sirdalud). Possible pharmacological interaction with rofecoxib (Vioxx)]. Kick A; Bertoli R; Moschovitis G; Caduff Janosa P; Cerny A Med Klin (Munich); 2005 Apr; 100(4):213-6. PubMed ID: 15834531 [TBL] [Abstract][Full Text] [Related]
32. [COX-2 inhibitors--one step forward and two steps back]. Evensen S; Spigset O; Slørdal L Tidsskr Nor Laegeforen; 2005 Apr; 125(7):875-8. PubMed ID: 15815733 [TBL] [Abstract][Full Text] [Related]
33. Tolerability of rofecoxib. Asero R Allergy; 2001 Sep; 56(9):916-7. PubMed ID: 11551261 [No Abstract] [Full Text] [Related]
34. [General practice study of therapy of acute pain. Patients prefer cox-2 inhibitors]. MMW Fortschr Med; 2004 May; 146(21):61. PubMed ID: 15373091 [No Abstract] [Full Text] [Related]
35. [COX-2 inhibitors and their effects on kidney and blood pressure]. Os I Tidsskr Nor Laegeforen; 2003 May; 123(10):1339-41. PubMed ID: 12806672 [No Abstract] [Full Text] [Related]
36. Acute cholestatic hepatitis associated with long-term use of rofecoxib. Papachristou GI; Demetris AJ; Rabinovitz M Dig Dis Sci; 2004 Mar; 49(3):459-61. PubMed ID: 15139498 [No Abstract] [Full Text] [Related]
37. The trade-off between cardiovascular and gastrointestinal effects of rofecoxib. Florentinus SR; Heerdink ER; de Boer A; van Dijk L; Leufkens HG Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):437-41. PubMed ID: 15937867 [TBL] [Abstract][Full Text] [Related]
38. [Slime fight in the lay media. Were the Vioxx fatal cases kept secret?]. Zierenberg O MMW Fortschr Med; 2004 Oct; 146(43):60. PubMed ID: 15559526 [No Abstract] [Full Text] [Related]
39. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG; Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361 [TBL] [Abstract][Full Text] [Related]